Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan.
about
Streptococcus pneumoniae Serotype Distribution and Pneumococcal Conjugate Vaccine Serotype Coverage among Pediatric Patients in East and Southeast Asia, 2000-2014: a Pooled Data AnalysisCombination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in miceNonhemolytic Streptococcus pyogenes isolates that lack large regions of the sag operon mediating streptolysin S production.Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in JapanThe burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study.Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typingInfluence of Pneumococcal Conjugate Vaccine on Acute Otitis Media with Severe Middle Ear Inflammation: A Retrospective Multicenter Study.Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in JapanControlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adultsSerotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Isolates from Adults in Korea from 1997 to 2012Vaccine chronicle in Japan.Theory and strategy for Pneumococcal vaccines in the elderly.Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution.Invasive Pneumococcal Disease (IPD) Serotype Frequency in Iranian Patients.Global prevailing and emerging pediatric pneumococcal serotypes.Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011.Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.Incidence of childhood pneumonia and serotype and sequence-type distribution in Streptococcus pneumoniae isolates in Japan.Serotype replacement of Streptococcus pneumoniae due to seven-valent pneumococcal conjugate vaccine in Japan.Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.Two cases of acute pneumococcal purulent arthritis.
P2860
Q26767050-29B94DC5-EDA5-49E7-953B-7C52DD357D42Q33594345-7E6B96B6-6021-4ED8-A4DC-F6DBC452C53AQ33627437-4F07E4CA-04ED-4DBF-BDA7-D1D6A2D3F01CQ34291076-3FF39116-9D2E-45F2-A3D3-E8F6672C744EQ34618641-DAD63A8F-6E35-4A6F-A77F-BB45E652CD84Q35231034-CD3DD9F9-5CE6-448E-9B52-D623B60516F9Q35592967-D56D86E5-C311-456E-8363-690C51DF6704Q35766672-7D3827AC-5D38-4D12-92A2-9FB8E5836242Q35887689-28CDFE87-4025-422D-9EAE-FEFEA674C2F1Q36131495-E51209BB-D126-437A-9FF9-A5F9A82266DDQ36191618-48968EAB-D366-450F-BE5A-249A6660D80AQ36229752-F07BB74D-30D1-439A-A7FB-CEDA0AD27CEDQ36255837-48858D72-605F-4110-9AC9-45E1BCCAA339Q36809649-A85638C0-1F6E-4915-8AD9-2C34CE0C514FQ37298594-985368C7-0914-40A6-AE77-6F122E837D5DQ37309215-4C9E78E8-D4D3-49E9-88E4-88DBF91A09C3Q37554742-80F3F435-E1D9-440F-9724-5C31B1697E7CQ37569208-8AA7185C-25F1-40B7-9682-410237912431Q37821484-D8641E95-76DF-43E2-A1BC-CDC4EF9DF311Q40192838-BCBEB6AB-6F19-42BE-85BC-D2B01018B228Q50327982-EE613790-5B86-4FD6-833C-14E5EB595A85Q51168983-2D1961BC-E4E5-4CFA-99D9-194D8EEE092CQ53730166-CA58AB23-4354-4929-BE1E-69801DBD352CQ53836109-C0BE8E27-CEE3-4C1F-AC05-BCCFEC1FCDDCQ54672720-0157AFEF-E6EA-4CE7-A8C7-12DB826BD984Q55307282-8B4E7AD8-DCE7-45B7-AD9E-E2F3DA406A40
P2860
Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@en
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@nl
type
label
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@en
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@nl
prefLabel
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@en
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@nl
P2093
P2860
P1476
Serotype and antibiotic resist ...... pneumococcal disease in Japan.
@en
P2093
IPD Surveillance Study Group
K Sunakawa
K Sunaoshi
M Morozumi
S Takahashi
P2860
P356
10.1017/S0950268809990239
P577
2009-06-19T00:00:00Z